Capital Advisors Ltd’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19K Sell
445
-205
-32% -$11.1K ﹤0.01% 701
2026
Q1
$41K Buy
650
+128
+25% +$10.2K ﹤0.01% 534
2025
Q4
$50K Hold
522
0.01% 479
2025
Q3
$51K Sell
522
-21
-4% -$2.17K 0.01% 463
2025
Q2
$58K Sell
543
-3
-0.5% -$304 0.01% 443
2025
Q1
$55K Hold
546
0.01% 438
2024
Q4
$49K Buy
546
+60
+12% +$5.28K 0.01% 454
2024
Q3
$41K Buy
486
+5
+1% +$394 0.01% 490
2024
Q2
$37K Buy
481
+95
+25% +$6.95K ﹤0.01% 495
2024
Q1
$26K Buy
386
+50
+15% +$3.21K ﹤0.01% 544
2023
Q4
$19K Hold
336
﹤0.01% 572
2023
Q3
$18K Hold
336
﹤0.01% 574
2023
Q2
$18K Hold
336
﹤0.01% 590
2023
Q1
$17K Buy
336
+72
+27% +$3.39K ﹤0.01% 476
2022
Q4
$12K Sell
264
-16
-6% -$693 ﹤0.01% 525
2022
Q3
$11K Buy
+280
New +$11.2K ﹤0.01% 524
2022
Q2
Sell
-31
Closed -$1K 1023
2022
Q1
$1K Buy
31
+14
+82% +$607 ﹤0.01% 678
2021
Q4
$1K Buy
+17
New +$714 ﹤0.01% 620

Other funds holding BSX

Capital Advisors Ltd's BSX Position: Q2 2026 in Review

Capital Advisors Ltd reduced its Boston Scientific (BSX) stake by 32% in Q2 2026, selling an estimated $11.1K and leaving 445 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #701.

Capital Advisors Ltd first reported a position in BSX in Q4 2021 and has held it in 18 quarters since. The position peaked at $58K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Capital Advisors Ltd held 445 shares of Boston Scientific worth $19K as of Q2 2026.
  • Capital Advisors Ltd sold 205 Boston Scientific shares in Q2 2026, an estimated $11.1K.
  • Boston Scientific made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #701 holding.
  • Capital Advisors Ltd first reported a position in Boston Scientific in Q4 2021 and has held it in 18 quarters since.
  • Capital Advisors Ltd's Boston Scientific position peaked at $58K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.